Journal of Breast Cancer Research

Commentary Open Access

How to inhibit breast cancer and breast cancer metastasis with Akt inhibitors: Lessons learned from studies in mice

Nissim Hay

The PI3K/Akt signaling pathway is frequently hyperactivated in different types of breast cancer. In the past two decades, major efforts have been made to develop inhibitors of this pathway to treat cancer patients. 

J Breast Cancer Res, 2021, Volume 1, Issue 2, p30-33 | DOI: 10.46439/breastcancer.1.007